Trexquant Investment’s Niagen Bioscience NAGE Stock Holding History

Trexquant Investment’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.54M	Buy	576,816 +140,484	+32%	+$759K	0.02%	903
2025 Q4	$2.78M	Sell	436,332 -6,127	-1%	-$42.6K	0.02%	859
2025 Q3	$4.13M	Buy	442,459 +308,572	+230%	+$3.12M	0.04%	619
2025 Q2	$1.93M	Sell	133,887 -75,899	-36%	-$749K	0.02%	900
2025 Q1	$1.45M	Buy	209,786 +182,603	+672%	+$1.15M	0.02%	974
2024 Q4	$144K	Buy	+27,183	New	+$149K	﹤0.01%	1495
2018 Q1	–	Sell	-43,748	Closed	-$257K	–	1441
2017 Q4	$257K	Buy	+43,748	New	+$236K	0.03%	815

Other funds holding NAGE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

TCM

Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Trexquant Investment's NAGE Position: Q1 2026 in Review

Trexquant Investment increased its Niagen Bioscience (NAGE) stake by 32% in Q1 2026, buying an estimated $759K and bringing the position to 576,816 shares worth $2.54M. The position accounts for 0.02% of the portfolio, ranked #903.

Trexquant Investment first reported a position in NAGE in Q4 2017 and has held it in 7 quarters since. The position peaked at $4.13M in Q3 2025. 143 funds tracked by Wall St. Rank hold NAGE as of Q1 2026.

Trexquant Investment held 576,816 shares of Niagen Bioscience worth $2.54M as of Q1 2026.
Trexquant Investment bought 140,484 Niagen Bioscience shares in Q1 2026, an estimated $759K.
Niagen Bioscience made up 0.02% of Trexquant Investment's portfolio in Q1 2026, its #903 holding.
Trexquant Investment first reported a position in Niagen Bioscience in Q4 2017 and has held it in 7 quarters since.
Trexquant Investment's Niagen Bioscience position peaked at $4.13M in Q3 2025.
143 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.